##################################################################################
# Document Properties Section

SET DOCUMENT Name = “Neuroinflammation”
SET DOCUMENT Description = “BEL file for Lab course at B-IT Uni Bonn”
SET DOCUMENT Version = "1.0"
SET DOCUMENT Copyright = "Copyright (c) 2012, lilit.antonyan. All Rights Reserved."
SET DOCUMENT Authors = "lilit.antonyan"
SET DOCUMENT Licenses = “CC 3.0”
SET DOCUMENT ContactInfo = “lilit.antonyan93@gmail.com"

##################################################################################
# Definitions Section

# NAMESPACE URLS

DEFINE NAMESPACE ADO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/ADO.belns"
DEFINE NAMESPACE AFFX AS URL "http://resource.belframework.org/belframework/20150611/namespace/affy-probeset-ids.belns"
DEFINE NAMESPACE BRCO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/BRCO.belns"
DEFINE NAMESPACE CHEBI AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi.belns"
DEFINE NAMESPACE CHEBIID AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi-ids.belns"
DEFINE NAMESPACE CHEMBL AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-names.belns"
DEFINE NAMESPACE CHEMBLID AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-ids.belns"
DEFINE NAMESPACE CTO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/CTO.belns"
DEFINE NAMESPACE DO AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology.belns"
DEFINE NAMESPACE DOID AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology-ids.belns"
DEFINE NAMESPACE EGID AS URL "http://resource.belframework.org/belframework/20150611/namespace/entrez-gene-ids.belns"
DEFINE NAMESPACE FlyBase AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Dmel.belns"
DEFINE NAMESPACE GOBP AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process.belns"
DEFINE NAMESPACE GOBPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process-ids.belns"
DEFINE NAMESPACE GOCC AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component.belns"
DEFINE NAMESPACE GOCCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component-ids.belns"
DEFINE NAMESPACE HGNC AS URL "http://resource.belframework.org/belframework/20150611/namespace/hgnc-human-genes.belns"
DEFINE NAMESPACE LMSD AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/LMSD.belns"
DEFINE NAMESPACE MESHC AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals.belns"
DEFINE NAMESPACE MESHCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals-ids.belns"
DEFINE NAMESPACE MESHCS AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures.belns"
DEFINE NAMESPACE MESHCSID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures-ids.belns"
DEFINE NAMESPACE MESHD AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases.belns"
DEFINE NAMESPACE MESHDID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases-ids.belns"
DEFINE NAMESPACE MESHPP AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes.belns"
DEFINE NAMESPACE MESHPPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes-ids.belns"
DEFINE NAMESPACE MGI AS URL "http://resource.belframework.org/belframework/20150611/namespace/mgi-mouse-genes.belns"
DEFINE NAMESPACE NIFT AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/NIFT.belns"
DEFINE NAMESPACE NTN AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Nutrition.belns"
DEFINE NAMESPACE PDO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PDO.belns"
DEFINE NAMESPACE PH AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/Placeholder.belns"
DEFINE NAMESPACE PMIBP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmibp.belns"
DEFINE NAMESPACE PMICHEM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmichem.belns"
DEFINE NAMESPACE PMICOMP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmicomp.belns"
DEFINE NAMESPACE PMIDIS AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmidis.belns"
DEFINE NAMESPACE PMIPFAM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmipfam.belns"
DEFINE NAMESPACE PTS AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PTS.belns"
DEFINE NAMESPACE RGD AS URL "http://resource.belframework.org/belframework/20150611/namespace/rgd-rat-genes.belns"
DEFINE NAMESPACE SCHEM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-chemicals.belns"
DEFINE NAMESPACE SCOMP AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-named-complexes.belns"
DEFINE NAMESPACE SDIS AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-diseases.belns"
DEFINE NAMESPACE SFAM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-protein-families.belns"
DEFINE NAMESPACE SP AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot.belns"
DEFINE NAMESPACE SPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot-ids.belns"
DEFINE NAMESPACE dbSNP AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/SNP.belns"


# ANNOTATION URLS

DEFINE ANNOTATION Anatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/anatomy.belanno"
DEFINE ANNOTATION BodyRegion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno"
DEFINE ANNOTATION CardiovascularSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno"
DEFINE ANNOTATION Cell AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell.belanno"
DEFINE ANNOTATION CellLine AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-line.belanno"
DEFINE ANNOTATION CellStructure AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-structure.belanno"
DEFINE ANNOTATION DigestiveSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno"
DEFINE ANNOTATION Disease AS URL "http://resource.belframework.org/belframework/20131211/annotation/disease.belanno"
DEFINE ANNOTATION FluidAndSecretion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno"
DEFINE ANNOTATION HemicAndImmuneSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno"
DEFINE ANNOTATION IntegumentarySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-anatomy.belanno"
DEFINE ANNOTATION MeSHDisease AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-diseases.belanno"
DEFINE ANNOTATION NervousSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno"
DEFINE ANNOTATION RespiratorySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno"
DEFINE ANNOTATION Species AS URL "http://resource.belframework.org/belframework/20131211/annotation/species-taxonomy-id.belanno"
DEFINE ANNOTATION Tissue AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno"
DEFINE ANNOTATION UrogenitalSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno"

##################################################################################
# Statements Section

SET STATEMENT_GROUP = "Group 1"

# Add statements below this comment

##################################################################
SET Citation ={"PubMed","Proc Natl Acad Sci U S A. 2014 May 27;111(21):7671-6. doi: 10.1073/pnas.1315346111. Epub 2014 May 9.", "24817693"}
SET Evidence ="We show that α-synuclein amyloid fibrils grow by monomer and not oligomer addition and 
are subject to higher-order assembly processes that decrease their capacity to grow. "

p(HGNC:SNCA) -> bp(GOBP:"amyloid fibril formation")

###################################################################
SET Citation = {"PubMed","J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.","24769233"}

SET Evidence = "The proteome of CSF EVs was enriched in exosomal markers such as alix and syntenin-1, 
heat shock proteins and tetraspanins and contained a high proportion of brain-derived proteins (n=373)."
SET FluidAndSecretion = "Cerebrospinal Fluid"

complex(GOCC:"extracellular vesicle") -> p(HGNC:PDCD6IP)
complex(GOCC:"extracellular vesicle") -> p(HGNC:SDCBP)
complex(GOCC:"extracellular vesicle") -> p(SFAM:"HSP90 Family")
 
SET Evidence = "Most interestingly, the involvement of extracellular vesicles in transferring toxic proteins such as α-synuclein and 
β-amyloid has been postulated as one of the mechanisms involved in the spreading of neurodegeneration to different brain areas."
SET NervousSystem = "Brain"

p(HGNC:SNCA) -- path(MESHD:"Neurodegenerative Diseases")
p(HGNC:APP) -- path(MESHD:"Neurodegenerative Diseases")

###################################################################
SET Citation = {"PubMed", "Neurobiol Dis. 2014 May;65:82-92. doi: 10.1016/j.nbd.2013.12.019. Epub 2014 Jan 9.", "24412310"}
SET Evidence = "We have recently shown the propagation of AD pathology via cell-to-cell transfer of oligomeric amyloid beta (Aβ) 
residues 1-42 (oAβ1-42) using our donor-acceptor 3-D co-culture model."

p(HGNC:APP) -- path(MESHD:"Alzheimer Disease")

###################################################################
SET Citation = {"PubMed", "Rev Neurol (Paris). 2013 Oct;169(10):825-33. doi: 10.1016/j.neurol.2013.07.018. Epub 2013 Sep 12.", "24035591"}
SET Evidence = "Finally, synthetic preformed fibrils of alpha-synuclein initiate the development of alpha-synuclein accumulation 
resembling Parkinson's disease in wild-type mice."
SET Species = "10090"

p(HGNC:SNCA) -- path(MESHD:"Parkinson Disease") 

###################################################################
SET Citation = {"PubMed", "Prion. 2013 Sep-Oct;7(5):369-77. doi: 10.4161/pri.26414. Epub 2013 Sep 10.", "24021964 "}
SET Evidence = "Prions are self-templating protein aggregates that were originally identified as the causative agent of prion diseases 
in mammals, but have since been discovered in other kingdoms. "

p(HGNC:PRNP) -- path(MESHD:"Prion Diseases")

###################################################################
SET Citation = {"PubMed", "Annu Rev Microbiol. 2013;67:543-64. doi: 10.1146/annurev-micro-092412-155735. Epub 2013 Jun 28.", " 23808331"}
SET Evidence = " Purified TSE prions usually take the form of amyloid fibrils, which are self-seeding ultrastructures common to many serious
protein misfolding diseases such as Alzheimer's, Parkinson's, Huntington's and Lou Gehrig's (amytrophic lateral sclerosis)."

p(HGNC:PRNP) -- path(MESHD:"Alzheimer Disease")
p(HGNC:PRNP) -- path(MESHD:"Parkinson Disease")
p(HGNC:PRNP) -- path(MESHD:"Huntington Disease")
p(HGNC:PRNP) -- path(MESHD:"Amyotrophic Lateral Sclerosis")

###################################################################
SET Citation = {"PubMed","Prion. 2013 Jul-Aug;7(4):276-9. doi: 10.4161/pri.25566. Epub 2013 Jun 27.","23807178"}
SET Species = "10090"
SET Evidence = "We propose that Prnp polymorphisms are one route by which certain prion strains may preferentially propagate. 
This has significant implications for prion disease, chronic wasting disease (CWD) in particular, as it is spreading through North America."

composite(bp(MESHPP:"Polymorphism, Genetic"), p(HGNC:PRNP)) -- path(MESHD:"Prion Diseases")
composite(bp(MESHPP:"Polymorphism, Genetic"), p(HGNC:PRNP)) -- path(DO:"chronic wasting disease")

####################################################################
SET Citation = {"PubMed", "Ann Neurol. 2011 Oct;70(4):532-40. doi: 10.1002/ana.22615.", "22028219"}
SET Evidence = "In Alzheimer disease (the most prevalent cerebral proteopathy), the two principal aggregating proteins are 
β-amyloid (Aβ) and tau. "

p(HGNC:MAPT) -- path(MESHD:"Alzheimer Disease")

SET Evidence = " The concept of prionlike induction and spreading of pathogenic proteins recently has been expanded to include aggregates of
tau, α-synuclein, huntingtin, superoxide dismutase-1, and TDP-43, which characterize such human neurodegenerative disorders as
frontotemporal lobar degeneration, Parkinson/Lewy body disease, Huntington disease, and amyotrophic lateral sclerosis. "

p(HGNC:MAPT) -- path(MESHD:"Frontotemporal Lobar Degeneration")
p(HGNC:MAPT) -- path(MESHD:"Parkinson Disease")
p(HGNC:MAPT) -- path(MESHD:"Huntington Disease")
p(HGNC:MAPT) -- path(MESHD:"Amyotrophic Lateral Sclerosis")
p(HGNC:SNCA) -- path(MESHD:"Frontotemporal Lobar Degeneration")
p(HGNC:SNCA) -- path(MESHD:"Parkinson Disease")
p(HGNC:SNCA) -- path(MESHD:"Huntington Disease")
p(HGNC:SNCA) -- path(MESHD:"Amyotrophic Lateral Sclerosis")
p(HGNC:HTT) -- path(MESHD:"Frontotemporal Lobar Degeneration")
p(HGNC:HTT) -- path(MESHD:"Parkinson Disease")
p(HGNC:HTT) -- path(MESHD:"Huntington Disease")
p(HGNC:HTT) -- path(MESHD:"Amyotrophic Lateral Sclerosis")
p(HGNC:SOD1) -- path(MESHD:"Frontotemporal Lobar Degeneration")
p(HGNC:SOD1) -- path(MESHD:"Parkinson Disease")
p(HGNC:SOD1) -- path(MESHD:"Huntington Disease")
p(HGNC:SOD1) -- path(MESHD:"Amyotrophic Lateral Sclerosis")
p(HGNC:TARDBP) -- path(MESHD: "Frontotemporal Lobar Degeneration")
p(HGNC:TARDBP) -- path(MESHD:"Parkinson Disease")
p(HGNC:TARDBP) -- path(MESHD:"Huntington Disease")
p(HGNC:TARDBP) -- path(MESHD:"Amyotrophic Lateral Sclerosis")

####################################################################
SET Citation = {"PubMed", "J Cell Sci. 2010 Apr 15;123(Pt 8):1191-201. doi: 10.1242/jcs.051672.", "20356930"}
SET Evidence = "These infectious phenotypes can be beneficial, as with yeast prions, or deleterious, 
as with mammalian prions that transmit spongiform encephalopathies. "

p(HGNC:PRNP) -- path(MESHD:"Encephalopathy, Bovine Spongiform")

SET Evidence = "Moreover, two RNA-binding proteins, FUS and TDP-43, which form cytoplasmic aggregates in amyotrophic lateral sclerosis, 
harbor a 'prion domain' similar to those found in several yeast prion proteins."

r(HGNC:FUS) -- path(MESHD:"Amyotrophic Lateral Sclerosis")
r(HGNC:TARDBP) -- path(MESHD:"Amyotrophic Lateral Sclerosis")

####################################################################
SET Citation = {"PubMed", "Mol Neurodegener. 2016 Aug 30;11(1):62. doi: 10.1186/s13024-016-0126-z.", "27578006"}
SET Evidence = "Surprisingly, we here show that one antibody, 4E6, which has low affinity for most forms of tau acutely improved cognition
and reduced soluble phospho-tau, whereas another antibody, 6B2, which has high affinity for various tau species was ineffective. "

a("antibody 4E6") -> bp(GOBP:"cognition")
a("antibody 4E6") -| p(HGNC:APP)
####################################################################  
SET Citation = {"PubMed", "Ann Neurol. 2016 Aug;80(2):247-58. doi: 10.1002/ana.24711. Epub 2016 Jul 8.", "27323247"}
SET Evidence = "Our PET study replicated postmortem spreading patterns of tau and amyloid-β pathologies. Unlike the diffuse accumulation 
of amyloid throughout the neocortex, tau spreading occurred in a stepwise fashion through the networks. "
SET NervousSystem = "Neocortex"

p(HGNC:APP) -- path(MESHD:"Postmortem Changes")

SET NervousSystem = "Nerve Net"

p(HGNC:MAPT) -- path(MESHD:"Postmortem Changes")

#####################################################################
SET Citation = {"PubMed", "J Neurochem. 2016 Aug;138 Suppl 1:71-94. doi: 10.1111/jnc.13600. Epub 2016 Jun 15.", "27306859"}
SET Evidence = "Frontotemporal lobar degeneration (FTLD) has been associated with toxic intracellular aggregates of 
hyperphosphorylated tau (FTLD-tau)"

phos(p(HGNC:MAPT)) -- path(MESHD:"Frontotemporal Lobar Degeneration") 

SET Evidence = " A disturbed tau distribution, as found in frontotemporal lobar degeneration (FTLD-tau), has severe consequences for 
cellular physiology: tau accumulates in the neuronal soma and dendrites, leading among others to microtubule depolymerization and 
impaired axonal transport. "

phos(p(HGNC:MAPT)) -> bp(GOBP:"microtubule depolymerization")
phos(p(HGNC:MAPT)) -> bp(MESHPP:"Axonal Transport")

SET Evidence = "Neuronal communication is gradually lost as toxic tau accumulates in dendritic spines with subsequent degeneration of 
synapses and synaptic loss."
SET NervousSystem = "Dendritic Spines"

p(HGNC:MAPT) -| bp(MESHPP:"Neural Conduction")

######################################################################
SET Citation = {"PubMed", "J Alzheimers Dis. 2016;51(2):345-56. doi: 10.3233/JAD-150859.", "26890756"}
SET NervousSystem = "Brain"
SET Evidence = "Tau becomes excessively phosphorylated in Alzheimer's disease (AD) and is widely studied within the brain. "

phos(p(HGNC:MAPT)) -- path(MESHD:"Alzheimer Disease")

SET Evidence = "Further examination of the extent and types of tau present in peripheral tissues and their relation to AD is warranted 
given recent publications on pathologic spreading. "
SET Anatomy = "peripheral nervous system"

p(HGNC:MAPT) -- path(MESHD:"Alzheimer Disease")

#########################################################################
SET Citation = {"PubMed", "J Alzheimers Dis. 2015;50(1):77-87. doi: 10.3233/JAD-150704.", "26638867"}
SET Evidence = "The microtubule-associated protein (MAP) tau plays a critical role in the pathogenesis of tauopathies."

p(HGNC:MAPT) -- path(MESHD:"Tauopathies")

#########################################################################
SET Citation = {"PubMed", "Biomed Res Int. 2015;2015:152926. doi: 10.1155/2015/152926. Epub 2015 Oct 25.", "26583089"}
SET Evidence = "Like other cancer cells, brain tumours can use EVs to secrete factors, which allow escaping from immune surveillance, 
and to transfer molecules into the surrounding cells, thus transforming their phenotype"

complex(GOCC:"extracellular vesicle") -| bp(MESHPP:"Immunologic Surveillance")

SET Evidence = "Intriguingly, EVs seem to be also involved in spreading through the brain of aggregated proteins, 
such as prions and aggregated tau protein."

complex(GOCC:"extracellular vesicle") -- p(HGNC:PRNP)
complex(GOCC:"extracellular vesicle") -- p(HGNC:MAPT)

SET Evidence = "Herein we summarize possible roles of EVs in brain physiological functions and discuss their involvement in 
the horizontal spreading, from cell to cell, of both cancer and neurodegenerative pathologies."

complex(GOCC:"extracellular vesicle") -- path(DO:"cancer")
complex(GOCC:"extracellular vesicle") -- path(MESHD:"Neurodegenerative Diseases")

#############################################################################

UNSET STATEMENT_GROUP










